Inventor · disambiguated record
Christopher Mcbride
Also filed as: MCBRIDE CHRISTOPHER
27 granted patents·12 pending applications·780 citations·filing 2001–2024
97Inventor score
Files withNOVARTIS VACCINES & DIAGNOSTIC9CHIRON CORP7GENENTECH INC6TAKEDA PHARMACEUTICALS CO4BURGER MATTHEW2
Top patents by PatentIndex Score
39 records- 0197US7642278B2Indazole benzimidazole compoundsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2005·Granted Jan 5, 2010·94 cites·12 claims
- 0297US6605617B2Quinolinone derivativesCHIRON CORP·Filed 2001·Granted Aug 12, 2003·174 cites·30 claims
- 0395US7482367B2Substituted benzimidazoles and methods of their useNOVARTIS VACCINES & DIAGNOSTIC·Filed 2006·Granted Jan 27, 2009·40 cites·2 claims
- 0495US7064215B2Indazole benzimidazole compoundsCHIRON CORP·Filed 2002·Granted Jun 20, 2006·130 cites·27 claims
- 0595US6774237B2Quinolinone derivativesCHIRON CORP·Filed 2002·Granted Aug 10, 2004·66 cites·23 claims
- 0694US7071216B2Substituted benz-azoles and methods of their use as inhibitors of Raf kinaseCHIRON CORP·Filed 2003·Granted Jul 4, 2006·37 cites·66 claims
- 0793US9434743B2Indazole derivativesTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Sep 6, 2016·20 cites·18 claims
- 0892US6800760B2Quinolinone derivativesCHIRON CORP·Filed 2003·Granted Oct 5, 2004·43 cites·20 claims
- 0992US6762194B2Quinolinone derivativesCHIRON CORP·Filed 2003·Granted Jul 13, 2004·46 cites·42 claims
- 1091US11702428B2Chemical compounds as inhibitors of interleukin-1 activityGENENTECH INC·Filed 2022·Granted Jul 18, 2023·1 cites·24 claims
- 1191US8614330B2Substituted benz-azoles and methods of their use as inhibitors of RAF kinaseAMIRI PAYMAN·Filed 2010·Granted Dec 24, 2013·11 cites·4 claims
- 1289US8822497B2PIM kinase inhibitors and methods of their useBURGER MATTHEW·Filed 2008·Granted Sep 2, 2014·10 cites·9 claims
- 1389US7470709B2Benzimidazole quinolinones and uses thereofNOVARTIS VACCINES & DIAGNOSTIC·Filed 2003·Granted Dec 30, 2008·36 cites·17 claims
- 1489US7335774B2Quinolinone derivativesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2005·Granted Feb 26, 2008·11 cites·12 claims
- 1588US11040985B2Chemical compounds as inhibitors of interleukin-1 activityGENENTECH INC·Filed 2019·Granted Jun 22, 2021·3 cites·74 claims
- 1687US7728010B2Substituted benz-azoles and methods of their use as inhibitors of Raf kinaseNOVARTIS VACCINES & DIAGNOSTIC·Filed 2005·Granted Jun 1, 2010·5 cites·40 claims
- 1785US8415382B2Substituted benzazoles and methods of their use as inhibitors of RAF KinaseCOSTALES ABRAN·Filed 2008·Granted Apr 9, 2013·15 cites·16 claims
- 1884US7732465B2Substituted benzimidazoles and methods of their useNOVARTIS VACCINES & DIAGNOSTIC·Filed 2008·Granted Jun 8, 2010·5 cites·3 claims
- 1984US7598268B2Quinolinone derivativesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2004·Granted Oct 6, 2009·14 cites·5 claims
- 2082US7423150B2Substituted benzazoles and methods of their use as inhibitors of Raf kinaseNOVARTIS AG·Filed 2004·Granted Sep 9, 2008·16 cites·48 claims
- 2176US9827255B2Fumagillol derivativesTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Nov 28, 2017·1 cites·37 claims
- 2275US2025115618A1Sulfonimidamide compounds as inhibitors of interleukin-1 activityGENENTECH INC·Filed 2024·Application pending·0 cites
- 2370US8592459B2Substituted benzimidazoles and methods of their useAIKAWA MINA E·Filed 2010·Granted Nov 26, 2013·2 cites·9 claims
- 2467US2021395268A1Chemical compounds as inhibitors of interleukin-1 activityGENENTECH INC·Filed 2021·Application pending·0 cites
- 2563US2008070906A1Quinolinone derivativesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2007·Application pending·0 cites
- 2661US12234245B2Sulfonimidamide compounds as inhibitors of interleukin-1 activityGENENTECH INC·Filed 2021·Granted Feb 25, 2025·0 cites·19 claims
- 2760US10328089B2Fumagillol derivativesTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Jun 25, 2019·0 cites·35 claims
- 2859US8202990B2Polo-like kinase inhibitorsMCBRIDE CHRISTOPHER·Filed 2008·Granted Jun 19, 2012·0 cites·1 claims
- 2959US2009281100A1Benzimidazole quinolinones and uses thereofBARSANTI PAUL A·Filed 2008·Application pending·0 cites
- 3058US2025059207A16,6-fused heterocyclic compounds as mettl3 inhibitors858 THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3157US2003028018A1Quinolinone derivativesCHIRON COPORATION·Filed 2002·Application pending·0 cites
- 3256US2010184754A1Quinolinone derivativesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2010·Application pending·0 cites
- 3354US11560391B2Sulfonylurea compounds as inhibitors of interleukin-1 activityGENENTECH INC·Filed 2021·Granted Jan 24, 2023·0 cites·21 claims
- 3454US2005203101A1Benzimidazole quinolinones and uses thereofCHIRON CORP·Filed 2004·Application pending·0 cites
- 3552US2010075973A1Polo-like kinase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2009·Application pending·0 cites
- 3651US2014249135A1Pim kinase inhibitors and methods of their useBURGER MATTHEW·Filed 2014·Application pending·0 cites
- 3750US2009291938A1Polo-like kinase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2008·Application pending·0 cites
- 3850US2013224195A1Substituted benzazoles and methods of their use as inhibitors of raf kinaseCOSTALES ABRAN·Filed 2013·Application pending·0 cites
- 3943US9475816B2Substituted-1,4-dihydropyrazolo[4,3-b]indolesTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Oct 25, 2016·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Christopher Mcbride files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →